OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cardiac abnormalities in Parkinson’s disease and Parkinsonism
Fulvio A. Scorza, Ana C. Fiorini, Carla A. Scorza, et al.
Journal of Clinical Neuroscience (2018) Vol. 53, pp. 1-5
Closed Access | Times Cited: 132
Fulvio A. Scorza, Ana C. Fiorini, Carla A. Scorza, et al.
Journal of Clinical Neuroscience (2018) Vol. 53, pp. 1-5
Closed Access | Times Cited: 132
Showing 1-25 of 132 citing articles:
Inflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments
Li Zuo, Evan R. Prather, Mykola Stetskiv, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4472-4472
Open Access | Times Cited: 402
Li Zuo, Evan R. Prather, Mykola Stetskiv, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4472-4472
Open Access | Times Cited: 402
Economics of Artificial Intelligence in Healthcare: Diagnosis vs. Treatment
Narendra N. Khanna, Mahesh Maindarkar, Vijay Viswanathan, et al.
Healthcare (2022) Vol. 10, Iss. 12, pp. 2493-2493
Open Access | Times Cited: 158
Narendra N. Khanna, Mahesh Maindarkar, Vijay Viswanathan, et al.
Healthcare (2022) Vol. 10, Iss. 12, pp. 2493-2493
Open Access | Times Cited: 158
Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics
Shahryar Shakeri, Milad Ashrafizadeh, Ali Zarrabi, et al.
Biomedicines (2020) Vol. 8, Iss. 1, pp. 13-13
Open Access | Times Cited: 109
Shahryar Shakeri, Milad Ashrafizadeh, Ali Zarrabi, et al.
Biomedicines (2020) Vol. 8, Iss. 1, pp. 13-13
Open Access | Times Cited: 109
Understanding the Links Between Cardiovascular Disease and Parkinson's Disease
Judy Potashkin, Xuemei Huang, Claudia Becker, et al.
Movement Disorders (2019) Vol. 35, Iss. 1, pp. 55-74
Open Access | Times Cited: 106
Judy Potashkin, Xuemei Huang, Claudia Becker, et al.
Movement Disorders (2019) Vol. 35, Iss. 1, pp. 55-74
Open Access | Times Cited: 106
Autonomic Dysfunction in α-Synucleinopathies
José Javier Mendoza-Velásquez, Juan Francisco Flores-Vázquez, Evalinda Barrón-Velázquez, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 97
José Javier Mendoza-Velásquez, Juan Francisco Flores-Vázquez, Evalinda Barrón-Velázquez, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 97
COVID-19: An Early Review of Its Global Impact and Considerations for Parkinson’s Disease Patient Care
Roongroj Bhidayasiri, Sasivimol Virameteekul, Jong‐Min Kim, et al.
Journal of Movement Disorders (2020) Vol. 13, Iss. 2, pp. 105-114
Open Access | Times Cited: 84
Roongroj Bhidayasiri, Sasivimol Virameteekul, Jong‐Min Kim, et al.
Journal of Movement Disorders (2020) Vol. 13, Iss. 2, pp. 105-114
Open Access | Times Cited: 84
A Case Report: Multifocal Necrotizing Encephalitis and Myocarditis after BNT162b2 mRNA Vaccination against COVID-19
Michael Mörz
Vaccines (2022) Vol. 10, Iss. 10, pp. 1651-1651
Open Access | Times Cited: 46
Michael Mörz
Vaccines (2022) Vol. 10, Iss. 10, pp. 1651-1651
Open Access | Times Cited: 46
Cardiovascular/Stroke Risk Stratification in Parkinson’s Disease Patients Using Atherosclerosis Pathway and Artificial Intelligence Paradigm: A Systematic Review
Jasjit S. Suri, Sudip Paul, Mahesh Maindarkar, et al.
Metabolites (2022) Vol. 12, Iss. 4, pp. 312-312
Open Access | Times Cited: 38
Jasjit S. Suri, Sudip Paul, Mahesh Maindarkar, et al.
Metabolites (2022) Vol. 12, Iss. 4, pp. 312-312
Open Access | Times Cited: 38
Ageing, the autonomic nervous system and arrhythmia: From brain to heart
Karan R. Chadda, Olujimi A. Ajijola, Marmar Vaseghi, et al.
Ageing Research Reviews (2018) Vol. 48, pp. 40-50
Closed Access | Times Cited: 61
Karan R. Chadda, Olujimi A. Ajijola, Marmar Vaseghi, et al.
Ageing Research Reviews (2018) Vol. 48, pp. 40-50
Closed Access | Times Cited: 61
Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research
Joana Lama, Yazead Buhidma, Edward J. R. Fletcher, et al.
Neuronal Signaling (2021) Vol. 5, Iss. 4
Open Access | Times Cited: 51
Joana Lama, Yazead Buhidma, Edward J. R. Fletcher, et al.
Neuronal Signaling (2021) Vol. 5, Iss. 4
Open Access | Times Cited: 51
Parkinson's disease and cardiovascular involvement: Edifying insights (Review)
Laura Grosu, Alin Grosu, Dana Crișan, et al.
Biomedical Reports (2023) Vol. 18, Iss. 3
Open Access | Times Cited: 19
Laura Grosu, Alin Grosu, Dana Crișan, et al.
Biomedical Reports (2023) Vol. 18, Iss. 3
Open Access | Times Cited: 19
Association of Abnormal P‐Wave Indices With Dementia and Cognitive Decline Over 25 Years: ARIC‐NCS (The Atherosclerosis Risk in Communities Neurocognitive Study)
Alejandra Gutiérrez, Faye L. Norby, Ankit Maheshwari, et al.
Journal of the American Heart Association (2019) Vol. 8, Iss. 24
Open Access | Times Cited: 44
Alejandra Gutiérrez, Faye L. Norby, Ankit Maheshwari, et al.
Journal of the American Heart Association (2019) Vol. 8, Iss. 24
Open Access | Times Cited: 44
Respiratory disorders of Parkinson’s disease
Yasmin C. Aquino, Laís M. Cabral, Nicole C. Miranda, et al.
Journal of Neurophysiology (2021) Vol. 127, Iss. 1, pp. 1-15
Closed Access | Times Cited: 38
Yasmin C. Aquino, Laís M. Cabral, Nicole C. Miranda, et al.
Journal of Neurophysiology (2021) Vol. 127, Iss. 1, pp. 1-15
Closed Access | Times Cited: 38
Angiotensin-converting enzyme inhibition prevents l-dopa-induced dyskinesia in a 6-ohda-induced mouse model of Parkinson's disease
Hye‐Yeon Park, Ga Seul Lee, Jun Go, et al.
European Journal of Pharmacology (2024) Vol. 973, pp. 176573-176573
Open Access | Times Cited: 5
Hye‐Yeon Park, Ga Seul Lee, Jun Go, et al.
European Journal of Pharmacology (2024) Vol. 973, pp. 176573-176573
Open Access | Times Cited: 5
Cardiac Changes in Parkinson’s Disease: Lessons from Clinical and Experimental Evidence
Lorena Cuenca‐Bermejo, Pilar Almela, Javier Navarro‐Zaragoza, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13488-13488
Open Access | Times Cited: 28
Lorena Cuenca‐Bermejo, Pilar Almela, Javier Navarro‐Zaragoza, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13488-13488
Open Access | Times Cited: 28
SGLT2 inhibitor empagliflozin alleviates cardiac remodeling and contractile anomalies in a FUNDC1-dependent manner in experimental Parkinson’s disease
Wei Yu, Lin Wang, Weiying Ren, et al.
Acta Pharmacologica Sinica (2023) Vol. 45, Iss. 1, pp. 87-97
Closed Access | Times Cited: 12
Wei Yu, Lin Wang, Weiying Ren, et al.
Acta Pharmacologica Sinica (2023) Vol. 45, Iss. 1, pp. 87-97
Closed Access | Times Cited: 12
Uncovering the Molecular Link Between Lead Toxicity and Parkinson's Disease
Liana Shvachiy, Vera Geraldes, Tiago F. Outeiro
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 4-6, pp. 321-335
Closed Access | Times Cited: 11
Liana Shvachiy, Vera Geraldes, Tiago F. Outeiro
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 4-6, pp. 321-335
Closed Access | Times Cited: 11
Exercise Strategies for Parkinson Disease Management
Spencer Ingoglia, B. Sue Graves
Strength and conditioning journal (2025)
Closed Access
Spencer Ingoglia, B. Sue Graves
Strength and conditioning journal (2025)
Closed Access
Restrictive Lung Disease from Parkinson’s Disease Rigidity
Shilpa C. Rao
Perioperative Medicine (2025), pp. 282-290
Open Access
Shilpa C. Rao
Perioperative Medicine (2025), pp. 282-290
Open Access
Cardiovascular disorders in Parkinson's disease
V. V. Yudina, О. N. Voskresenskaya
Russian neurological Journal (2025) Vol. 29, Iss. 6, pp. 15-19
Closed Access
V. V. Yudina, О. N. Voskresenskaya
Russian neurological Journal (2025) Vol. 29, Iss. 6, pp. 15-19
Closed Access
Intact microdissection of stellate ganglia in a Parkinson's disease model reveals aggregation of mutant human α‐synuclein in their cell bodies
Bonn Lee, Shiraz Ahmad, Charlotte E. Edling, et al.
Experimental Physiology (2025)
Open Access
Bonn Lee, Shiraz Ahmad, Charlotte E. Edling, et al.
Experimental Physiology (2025)
Open Access
PARKINSON’S DISEASE: NEWS ON THE ACTION OF MELATONIN
Fulvio A Scorza, Raphael Wuo‐Silva, Josef Finsterer, et al.
Sleep Medicine (2025) Vol. 130, pp. 1-2
Closed Access
Fulvio A Scorza, Raphael Wuo‐Silva, Josef Finsterer, et al.
Sleep Medicine (2025) Vol. 130, pp. 1-2
Closed Access
Amantadine Reduces Adverse Cardiovascular Outcomes in Patients With Parkinsonism or Parkinson Disease: A Global Propensity Score Matched Analysis
Dan Draytsel, Anderson Anuforo, Subaina Khalid, et al.
Clinical Neuropharmacology (2025)
Closed Access
Dan Draytsel, Anderson Anuforo, Subaina Khalid, et al.
Clinical Neuropharmacology (2025)
Closed Access
Response to “Letter to the Editor regarding ‘Parkinson’s Disease: News on the Action of Melatonin’ by Scorza et al”
Ramkumar Sugumaran, Kadarla Shiva Sai Krishna, Jayaram Saibaba, et al.
Sleep Medicine (2025) Vol. 130, pp. 13-14
Closed Access
Ramkumar Sugumaran, Kadarla Shiva Sai Krishna, Jayaram Saibaba, et al.
Sleep Medicine (2025) Vol. 130, pp. 13-14
Closed Access
Cardiovascular health and its association with dementia, Parkinson’s Disease, and mortality among UK older adults
Michael F. Georgescu, May A. Beydoun, Jordan Weiss, et al.
Brain Behavior & Immunity - Health (2025), pp. 100986-100986
Open Access
Michael F. Georgescu, May A. Beydoun, Jordan Weiss, et al.
Brain Behavior & Immunity - Health (2025), pp. 100986-100986
Open Access
